Please login to the form below

Not currently logged in


This page shows the latest Tavlesse news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

The agency’s recommendation was based on cost-effectiveness estimates of Tavlesse compared with rituximab. ... Tavlesse] will be another tool for haematologists to use in supporting patients with chronic ITP.”.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
Origins - The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...